Tethys predicts your potential diabetic future
Suppose a simple blood test were to tell you that you’ve got a better than 50 percent chance of developing “type 2″ diabetes — a form of the disease long associated with age and obesity — within the next five years. Would you make the… Continue Reading
Biomarker-diagnostics developer Singulex validates $19M
Hayward, Calif.-based Singulex, a developer of sensitive molecular-detection systems, raised $19 million in a fourth funding round. The company’s release is here.
The company is developing an analysis system, called Erenna, plus related “assays,” or specially designed biochemical tests, that are designed to detect individual protein… Continue Reading
Biotech Roundup: Heart-disease biomarkers, drugs that go too far, “non-profit” drugs
(Note: This item has been copied over to the Life Sciences page from its original location on the VentureBeat main page. To view it in its original context, with comments, click here.)
Cautionary tales: An occasional look at events with potential long-term impact for biotechnology
Personalized medicine… Continue Reading
Biotech Roundup: Heart-disease biomarkers, drugs that go too far, “non-profit” drugs
Cautionary tales: An occasional look at events with potential long-term impact for biotechnology
Personalized medicine takes a hit — Scientists have spent more than a decade scouring the human genome to identify genetic alterations that might predict your risk of developing, say, heart trouble or cancer. Now,… Continue Reading